[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342295-105":59,"doc-detail-342295-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","flow-cytometric-assessment-of-fcriiia-v158f-polymorphisms-and-nk-cell-mediated-adcc-revealed-reduced-nk-cell-functionality-in-colorectal-cancer-patients","Flow Cytometric Assessment of FcγRIIIa-V158F Polymorphisms and NK Cell Mediated ADCC Revealed Reduced NK Cell Functionality in Colorectal Cancer Patients","","Antibody-dependent cell-mediated cytotoxicity (ADCC) by NK cells is a central mechanism of anti-cancer monoclonal antibody therapies, and Fc gamma receptor IIIa (FcγRIIIa) polymorphisms are known to affect ADCC. Their clinical relevance to NK cell functionality remains debated. The study developed two complementary flow cytometry assays: a machine-learning approach to predict FcγRIIIa-V158F and a 15-color panel to quantify antibody-induced NK cell function and cancer-immune interactions. Using samples from healthy donors and metastatic colorectal cancer patients, the model predicted the polymorphism in 94% of cases. FF homozygotes showed reduced cetuximab-mediated ADCC, with NK cell dysfunctions including impaired ADCC, decreased CD16 downregulation, and reduced CD137/CD107a induction. Elevated PD1+ NK cell levels, diminished lysis of PD-L1-expressing CRC cells, and enhanced activation with the PD-L1-targeting avelumab support a role for the PD1–PD-L1 axis in impaired cetuximab-induced NK cell function.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/flow-cytometric-assessment-of-fcriiia-v158f-polymorphisms-and-nk-cell-mediated-adcc-revealed-reduced-nk-cell-functionality-in-colorectal-cancer-patients/342295/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/flow-cytometric-assessment-of-fcriiia-v158f-polymorphisms-and-nk-cell-mediated-adcc-revealed-reduced-nk-cell-functionality-in-colorectal-cancer-patients/342295.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of the study in colorectal cancer patients?","Question",{"text":112,"@type":113},"To evaluate how FcγRIIIa-V158F polymorphisms relate to NK-cell mediated ADCC and overall NK cell functionality in metastatic colorectal cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers assess FcγRIIIa-V158F polymorphisms?",{"text":117,"@type":113},"They developed a machine learning model trained to predict the FcγRIIIa-V158F polymorphism, achieving accurate predictions across samples.",{"name":119,"@type":110,"acceptedAnswer":120},"What NK cell functional impairments were observed in mCRC patients and FF homozygotes?",{"text":121,"@type":113},"FF homozygous patients showed diminished cetuximab-mediated ADCC, and mCRC patients exhibited impaired ADCC, decreased CD16 downregulation, and reduced CD137/CD107a induction.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342295,1790878956,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Article  \nFlow Cytometric Assessment of FcγRIIIa-V158F Polymorphismsand NK Cell Mediated ADCC Revealed Reduced NK Cell Functionality in Colorectal Cancer Patients  \nPhillip Schiele 1,2, *,†, Stefan Kolling 1,2,3,4,†, Stanislav Rosnev 2, Charlotte Junkuhn 1,2,4, Anna Luzie Walter 1,2,4,5, Jobst Christian von Einem 2,6, Sebastian Stintzing 2, Wenzel Schöning 7,  \nIgor Maximilian Sauer 8, Dominik Paul Modest 2,9, Kathrin Heinrich 10, Lena Weiss 11, Volker Heinemann 11, Lars Bullinger 2, Marco Frentsch 1,2,‡ and Il-Kang Na 1,2,4,9,12,13, *,‡  \nAcademic Editors: Fuguo Liu,  \nMubin Tarannum and Yingjie Zhao Received: 24 November 2024  \nRevised: 17 December 2024  \nAccepted: 24 December 2024  \nPublished: 31 December 2024  \nCitation: Schiele, P.; Kolling, S.; Rosnev, S.; Junkuhn, C.; Walter, A.L.; von Einem, J.C.; Stintzing, S.; Schöning, W.; Sauer, I.M.; Modest, D.P.; et al. Flow Cytometric Assessment of FcγRIIIa-V158F Polymorphisms and NK Cell Mediated ADCC Revealed Reduced NK Cell Functionality in Colorectal Cancer Patients. Cells 2025, 14, 32 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)cells14010032  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 BIH Center for Regenerative Therapies (BCRT), Therapy-Induced Remodeling in Immuno-Oncology, Berlin Institute of Health at Charité—Universitätsmedizin Berlin, 13353 Berlin, Germany  \n2 Department of Hematology, Oncology and Cancer Immunology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt—Universität zu Berlin, 13353 Berlin, Germany  \n3 BIH Biomedical Innovation Academy, BIH Charité Junior Digital Clinician Scientist Program, Berlin Institute of Health at Charité—Universitätsmedizin Berlin, 10178 Berlin, Germany  \n4 BSIO Berlin School of Integrative Oncology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10178 Berlin, Germany  \n5 Medical Department of Hematology, Oncology and Tumor Immunology, Molekulares Krebsforschungszentrum (MKFZ), Charité—Universitätsmedizin, 10117 Berlin, Germany  \n6 MVZ Onkologie Tiergarten, 10559 Berlin, Germany  \n7 Department of Surgery, Campus Charité Mitte—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt—Universität zu Berlin, 10117 Berlin, Germany  \n8 Department of Surgery, Campus Virchow Klinikum, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt—Universität zu Berlin, 13353 Berlin, Germany  \n9 German Cancer Consortium (DKTK), 10115 Berlin, Germany  \n10 Department of Medicine III, Ludwig-Maximilians-University of Munich, 80539 Munich, Germany  \n11 Department of Hematology/Oncology and Comprehensive Cancer Center, University Hospital, Klinikum Grosshadern, Ludwig-Maximilians-University of Munich, 80539 Munich, Germany  \n12 ECRC Experimental and Clinical Research Center, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt—Universität zu Berlin, 10178 Berlin, Germany  \n13 Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany  \n* Correspondence: phillip.schiele@charite.de (P.S.); [il-kang.na@bih-charite.de](il-kang.na@bih-charite.de) (I.-K.N.)† These authors contributed equally to this work.  \n‡ These authors co-supervised the study.  \nAbstract: Antibody-dependent cell-mediated cytotoxicity (ADCC) by NK cells is a key mechanism in anti-cancer therapies with monoclonal antibodies, including cetuximab (EGFR-targeting) and avelumab (PDL1-targeting) . Fc gamma receptor IIIa (FcγRIIIa) polymorphisms impact ADCC, yet their clinical relevance in NK cell functio","cbCaicrZ6nQH0gmm","https://ap.wps.com/l/cbCaicrZ6nQH0gmm","pdf",2980415,18,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"What was the main goal of the study in colorectal cancer patients?\",\"answer\":\"To evaluate how FcγRIIIa-V158F polymorphisms relate to NK-cell mediated ADCC and overall NK cell functionality in metastatic colorectal cancer.\"},{\"question\":\"How did the researchers assess FcγRIIIa-V158F polymorphisms?\",\"answer\":\"They developed a machine learning model trained to predict the FcγRIIIa-V158F polymorphism, achieving accurate predictions across samples.\"},{\"question\":\"What NK cell functional impairments were observed in mCRC patients and FF homozygotes?\",\"answer\":\"FF homozygous patients showed diminished cetuximab-mediated ADCC, and mCRC patients exhibited impaired ADCC, decreased CD16 downregulation, and reduced CD137/CD107a induction.\"}]","Flow Cytometric Assessment of FcγRIIIa-V158F Polymorphisms and NK Cell Mediated ADCC Revealed Reduced NK Cell Functionality in Colorectal Cancer Patients | PDF",1790046042,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fbb02d21701c32b31e64de850068e7df.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/18bde73f0cdce91cfcc2e89024d6a527.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7b61a3fd53230f3fc5a71752217ef207.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/85c4d8e2a22feadd9da02d3272c970e8.webp",980,1385]